clarithromycin has been researched along with su 11248 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Esaki, T; Kawashima, H; Komura, H; Kuroda, M; Mizuguchi, K; Natsume-Kitatani, Y; Ohashi, R; Watanabe, R | 1 |
| Grabowski, T; Grześkowiak, E; Karbownik, A; Matuszewski, M; Połom, W; Sobańska, K; Szałek, E; Urjasz, H; Wolc, A | 1 |
1 review(s) available for clarithromycin and su 11248
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for clarithromycin and su 11248
| Article | Year |
|---|---|
Development of an
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Computer Simulation; Endothelial Cells; Gene Knockout Techniques; Humans; Organic Chemicals; Rats, Transgenic | 2021 |
Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not?
Topics: Administration, Oral; Animals; Area Under Curve; Azithromycin; Chromatography, High Pressure Liquid; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Half-Life; Indoles; Isoenzymes; Male; Metabolic Clearance Rate; Protein Kinase Inhibitors; Pyrroles; Rabbits; Risk Assessment; Spectrophotometry, Ultraviolet; Sunitinib | 2012 |